Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Acoltremon by Alcon for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Acoltremon is under clinical development by Alcon and currently in Phase III for Keratoconjunctivitis Sicca (Dry Eye). According to GlobalData,...